NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Hankman-Mimivax owns Survax so no Nwbo doesn’t control. Edens could theoretically be used to produce Survax in phase 3 trials once Eden’s gets certified. However, Eden’s will be in high demand for commercial production of L and for L combo trials going forward and for trials underway on non GBM indications both at Nwbo and Roswell.

Eden cannot be used to produce SurVaxM, even a novice in the field should be able to see that.

As far as Eden being in high demand for commercial production, I will say zero for the next 3 years. Check back later.